{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:01:20Z","timestamp":1780635680057,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T00:00:00Z","timestamp":1729382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["MSII\/00007"],"award-info":[{"award-number":["MSII\/00007"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["FI21\/00146"],"award-info":[{"award-number":["FI21\/00146"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007406","name":"Fundaci\u00f3n BBVA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013941","name":"Biomedical Research Network Centre of Diabetes and Associated Metabolic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Department of Health","doi-asserted-by":"publisher","award":["FPU22\/01888"],"award-info":[{"award-number":["FPU22\/01888"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Department of Health","doi-asserted-by":"publisher","award":["FPU21\/01173"],"award-info":[{"award-number":["FPU21\/01173"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012513","name":"Biomedical Research Network Centre in Cardiovascular Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.atherosclerosis.2024.118630","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T16:01:22Z","timestamp":1729353682000},"page":"118630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization"],"prefix":"10.1016","volume":"410","author":[{"given":"A.","family":"Benitez-Amaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"La Chica Lho\u00ebst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Borr\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"C\u00e9spedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Caruana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bochicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cenarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Civeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Prades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Escola-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Llorente-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.118630_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00041433-200410000-00003","article-title":"Mechanism of lipoprotein retention by the extracellular matrix","volume":"15","author":"Gustafsson","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib2","first-page":"43","article-title":"Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation","volume":"103","author":"Tran-Lundmark","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.118630_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.atherosclerosis.2012.08.040","article-title":"HDL2 interferes with LDL association with arterial proteoglycans: a possible athero-protective effect","volume":"225","author":"Umaerus","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib4","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1172\/JCI118934","article-title":"Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins","volume":"98","author":"Schissel","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib5","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1194\/jlr.M023218","article-title":"Conformational changes of apoB-100 in SMase-modified LDL mediate formation of large aggregates at acidic pH","volume":"53","author":"Sneck","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/hq0302.105367","article-title":"Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors","volume":"22","author":"Llorente-Cort\u00e9s","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib7","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1161\/01.CIR.0000041434.28573.0B","article-title":"Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism","volume":"106","author":"Llorente-Cort\u00e9s","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.atherosclerosis.2010.09.034","article-title":"Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression","volume":"213","author":"Costales","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib9","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/ATVBAHA.111.225490","article-title":"Hypoxia stimulates low-density lipoprotein receptor-related protein-1 expression through hypoxia-inducible factor-1\u03b1 in human vascular smooth muscle cells","volume":"31","author":"Castellano","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/01.CIR.0000136032.40666.3D","article-title":"Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells","volume":"110","author":"Llorente-Cort\u00e9s","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cardiores.2006.10.017","article-title":"Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells","volume":"73","author":"Camino-L\u00f3pez","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib12","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/eurheartj\/ehy319","article-title":"Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths","volume":"39","author":"Ruuth","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2020.11.016","article-title":"Low-density lipoprotein aggregation predicts adverse cardiovascular events in peripheral artery disease","volume":"316","author":"Heffron","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1471-4914(02)02382-1","article-title":"Atherosclerosis: another protein misfolding disease?","volume":"8","author":"Ursini","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2019.06.904","article-title":"Soluble low-density lipoprotein receptor-related protein 1 as a biomarker of coronary risk: predictive capacity and association with clinical events","volume":"287","author":"de Gonzalo-Calvo","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12967-022-03867-w","article-title":"Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by 18F-FDG PET in patients with a recent ischemic stroke","volume":"21","author":"Garcia","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib17","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1074\/jbc.M115.638361","article-title":"Domain CR9 of low density lipoprotein (LDL) receptor-related protein 1 (LRP1) is critical for aggregated LDL-induced foam cell formation from human vascular smooth muscle cells","volume":"290","author":"Costales","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib18","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbamem.2019.05.003","article-title":"Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation","volume":"1861","author":"Benitez-Amaro","year":"2019","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib19","doi-asserted-by":"crossref","first-page":"2000037","DOI":"10.1002\/adtp.202000037","article-title":"Development of innovative antiatherosclerotic peptides through the combination of molecular modeling and a dual (Biochemical\u2010Cellular) screening system","volume":"3","author":"Benitez Amaro","year":"2020","journal-title":"Advanced Therapeutics"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib20","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.1125884","article-title":"Biomedicine. Lowering LDL--not only how low, but how long?","volume":"311","author":"Brown","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib21","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.3390\/jcm10163571","article-title":"Apolipoprotein and LRP1-based peptides as new therapeutic tools in atherosclerosis","volume":"10","author":"Benitez Amaro","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib22","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1194\/jlr.M059485","article-title":"Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation","volume":"56","author":"Nguyen","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib23","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1096\/fj.14-264036","article-title":"Clusterin\/apolipoprotein J binds to aggregated LDL in human plasma and plays a protective role against LDL aggregation","volume":"29","author":"Mart\u00ednez-Bujidos","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib24","doi-asserted-by":"crossref","first-page":"158541","DOI":"10.1016\/j.bbalip.2019.158541","article-title":"Low-density lipoprotein aggregation is inhibited by apolipoprotein J-derived mimetic peptide D-[113-122] apoJ","volume":"1865","author":"Rivas-Urbina","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/cancers14040890","article-title":"Peptides against low density lipoprotein (LDL) aggregation inhibit intracellular cholesteryl ester loading and proliferation of pancreatic tumor cells","volume":"14","author":"Benitez-Amaro","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cvr\/cvy143","article-title":"Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice","volume":"115","author":"Ruotsalainen","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib27","first-page":"730","volume":"113","author":"G\u00f3mez-Gerique","year":"1999","journal-title":"Med. Clin."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib28","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib29","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/ATV.0000000000000062","article-title":"Recommendation on design, execution, and reporting of animal atherosclerosis studies: a scientific statement from the American heart association","volume":"37","author":"Daugherty","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCULATIONAHA.117.030856","article-title":"Vascular smooth muscle-specific progerin expression accelerates atherosclerosis and death in a mouse model of hutchinson-gilford progeria syndrome","volume":"138","author":"Hamczyk","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib31","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.bbapap.2014.10.001","article-title":"Protein helical structure determination using CD spectroscopy for solutions with strong background absorbance from 190 to 230 nm","volume":"1844","author":"Wei","year":"2014","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/ATVBAHA.111.237693","article-title":"Animal models of atherosclerosis","volume":"32","author":"Getz","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib33","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.tips.2022.06.009","article-title":"Mouse models of atherosclerosis in translational research","volume":"43","author":"Ilyas","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1172\/JCI119511","article-title":"Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100","volume":"100","author":"V\u00e9niant","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib35","doi-asserted-by":"crossref","first-page":"32228","DOI":"10.1074\/jbc.M204053200","article-title":"Identification of the proteoglycan binding site in apolipoprotein B48","volume":"277","author":"Flood","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib36","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1039\/B700706J","article-title":"The physiological and molecular regulation of lipoprotein assembly and secretion","volume":"3","author":"Blasiole","year":"2007","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.nutr.20.1.169","article-title":"mRNA editing, lipoprotein assembly, and presecretory degradation","volume":"20","author":"Davidson","year":"2000","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.ATV.14.4.501","article-title":"ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm","volume":"14","author":"Fisher","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib39","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm0898-934","article-title":"A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet","volume":"4","author":"Powell-Braxton","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib40","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1073\/pnas.95.8.4544","article-title":"Low-density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a)","volume":"95","author":"Sanan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib41","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1073\/pnas.85.6.1772","article-title":"Human apolipoprotein B (apoB) mRNA: identification of two distinct apoB mRNAs, an mRNA with the apoB-100 sequence and an apoB mRNA containing a premature in-frame translational stop codon, in both liver and intestine","volume":"85","author":"Higuchi","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1388-1981(00)00123-2","article-title":"Structure of low-density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL","volume":"1488","author":"Hevonoja","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib43","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0022-2275(20)30267-4","article-title":"Structure of apolipoprotein B-100 in low density lipoproteins","volume":"42","author":"Segrest","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib44","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/323738a0","article-title":"Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100","volume":"323","author":"Yang","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib45","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0006-291X(86)80287-X","article-title":"Identification of low-density lipoprotein receptor binding domains of human apolipoprotein B-100: a proposed consensus LDL receptor binding sequence of apoB-100","volume":"139","author":"Hospattankar","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib46","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1172\/JCI2265","article-title":"Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding","volume":"101","author":"Bor\u00e9n","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(98)00107-5","article-title":"Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis","volume":"139","author":"Camejo","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib48","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in earlybatherosclerosis","volume":"417","author":"Sk\u00e5l\u00e9n","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.dmpk.2018.11.001","article-title":"Pharmacokinetics of protein and peptide conjugates","volume":"34","author":"Bumbaca","year":"2019","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.atherosclerosis.2024.118630_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2021.06.903","article-title":"The emerging landscape of peptide-based inhibitors of PCSK9","volume":"330","author":"Tombling","year":"2021","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024012024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024012024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:27:32Z","timestamp":1780633652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024012024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0021915024012024"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118630","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting LDL aggregation decreases atherosclerotic lipid burden in a humanized mouse model of familial hypercholesterolemia: Crucial role of ApoB100 conformational stabilization","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"118630"}}